Mankind Pharma Limited announced on June 4, 2025, that ISS ESG has voluntarily issued an ESG Corporate Rating Report for the company on June 3, 2025.

• The report, based on publicly available data, assigned Mankind Pharma an overall ESG score of 38.98, corresponding to a C- rating.
• The company clarified that it has not verified any data on which this rating has been issued.